Hostacortin

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hostacortin

Quick Facts

Property Description
Active ingredient Prednisolone Acetate (INN)
Form Suspension, Solution, Tablets
Pharmacological class Synthetic Glucocorticoid (Corticosteroid)
General purpose Anti-inflammatory and Immunosuppressive
Origin Synthetic (Ester derivative)

What Type of Medicine is Hostacortin?

Hostacortin is a pharmaceutical preparation whose active component is Prednisolone Acetate, classifying it within the potent Corticosteroid Hormone class. It is specifically a synthetic glucocorticoid, a compound manufactured to enhance the powerful anti-inflammatory and immunosuppressive effects of the natural human hormone cortisol. The drug's efficacy in suppressing inflammation establishes it as a standard treatment option for immune-mediated conditions.

This drug is a single-ingredient product available in multiple forms, including tablets for systemic (oral) administration and sterile suspensions or solutions designed for specialized ophthalmic use. The classification as a glucocorticoid highlights its fundamental function as a powerful modulator of the body's immune and inflammatory processes.

Prednisolone Acetate: Composition and Unique Form

The composition of Hostacortin centers on the active ingredient, Prednisolone Acetate, which is a manufactured ester derivative of the base compound, prednisolone. The compound is entirely synthetic in origin, allowing for predictable and concentrated therapeutic effects that exceed the potency of naturally derived corticosteroids.

The acetate structure, a key differentiating factor, functions as a chemical configuration designed primarily for enhanced stability and targeted delivery, a feature particularly beneficial when formulated as an ophthalmic suspension or solution. Upon administration, the compound is designed to undergo rapid chemical breakdown, known as ester hydrolysis, which quickly releases the fully active and therapeutic prednisolone component to exert its effects.

What is the General Purpose of This Glucocorticoid?

The general purpose of this glucocorticoid is to act as a powerful Anti-inflammatory Agent and Immunosuppressive Agent to control intense immune and inflammatory overactivity. It achieves this by profoundly reducing the cellular reactions that trigger and sustain the symptoms of inflammation, such as swelling, redness, and discomfort.

A typical neutral use scenario involves the management of severe, non-infectious inflammatory reactions, such as those caused by strong allergic states. The core utility lies in its capacity to serve as a comprehensive brake on the inflammatory cascade, thereby providing broad control over conditions rooted in unchecked inflammation.

What side effects are possible with Hostacortin?

Hostacortin, containing the glucocorticoid prednisolone, has an official safety profile defined by expected effects of systemic corticosteroid therapy. Adverse reactions are classified by frequency and affected body system, as documented in regulatory sources.

Official Adverse Reaction Classifications

Adverse reactions are organized by System-Organ-Class (SOC) in regulatory documents, with effects noted across several body systems:

  • Endocrine and Metabolic: Commonly includes weight gain, increased appetite, and a documented risk of HPA axis suppression with prolonged systemic exposure.
  • Musculoskeletal: Long-term use is associated with a decrease in bone density, leading to osteoporosis, and muscle weakness.
  • Gastrointestinal: Regulatory labels document the risk of serious adverse reactions, specifically peptic ulceration with potential for perforation and hemorrhage.
  • Ophthalmic: Both systemic and local use are associated with the risk of posterior subcapsular cataract formation and increased intraocular pressure (glaucoma), particularly with prolonged use.
  • Nervous System and Psychiatric: Effects include euphoria, insomnia, mood swings, and the potential for severe psychiatric disturbances (e.g., psychosis).

Safety Considerations and Restrictions

Certain risks are tied to the duration of use, requiring monitoring, such as the routine check of intraocular pressure during extended ophthalmic administration. The drug is classified as an immunosuppressive agent and carries documented restrictions against the use of live or live attenuated vaccines during treatment. Abrupt discontinuation following prolonged systemic exposure is noted to carry the risk of acute adrenal insufficiency.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documentation states that an acute overdosage of the active ingredient, Prednisolone Acetate, will not ordinarily cause acute toxicity, particularly when using the ophthalmic formulation via its intended route.

Documented Manifestations and Emergency Action

Despite the low acute risk, regulatory guidance mandates immediate medical attention for the emergence of severe signs associated with excessive glucocorticoid exposure. These manifestations may include convulsions (seizures), significant altered mental status (psychic derangements), trouble breathing, or cardiac rhythm disturbances. The appearance of severe hypertension or edema is also a documented concern following massive exposure.

If any severe manifestation or a suspected overdose occurs, it is required to contact emergency services or a poison control helpline immediately.

Management and Monitoring

In overdose cases, regulatory information confirms that no specific antidote is known. Therefore, the established approach for management is symptomatic and supportive treatment. This may necessitate hospital monitoring involving the checking of vital signs, performing an ECG (heart tracing), and obtaining specific blood and urine tests. If the ophthalmic solution is accidentally ingested, regulatory instructions advise drinking fluids to dilute the product.

Therapeutic Uses of Hostacortin

What Hostacortin Treats: Main Uses and Benefits

Hostacortin, containing the active ingredient prednisolone, is a systemic corticosteroid medication applied across domains where additional symptomatic support is needed. This medication is commonly used to help with a variety of conditions, particularly in situations involving certain distressing symptoms or conditions presenting with systemic or localized discomfort.

Prednisolone may be applied in addressing acute or episodic manifestations of conditions like various forms of arthritis, severe allergic reactions, asthma, inflammatory bowel diseases, and certain blood and eye disorders. It is relevant in contexts marked by increased discomfort or tension, particularly during phases when symptoms become more noticeable. The use of prednisolone may assist with supportive relief when symptoms that interfere with daily functioning become temporarily overwhelming. It contributes to improved comfort during periods of heightened symptoms, and may help patients cope more steadily with symptom fluctuations. The medication is used for easing symptoms related to inflammatory or irritative states and helps ease swelling and redness.


Quick Fact: Helps manage Symptoms related to inflammatory or irritative states

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility for Hostacortin Use

Hostacortin (Prednisolone Acetate) eligibility is determined by regulatory authorities based on absolute prohibitions and conditional use requirements.


Absolute Contraindications

The medicine is contraindicated and must not be used by individuals with a known or suspected hypersensitivity to the active ingredient or any component of the formulation. Use of the ophthalmic form is also prohibited in the presence of most viral, mycobacterial, and fungal infections of the eye, including epithelial herpes simplex keratitis. Systemic use is prohibited in the presence of systemic fungal infections.


Conditional Use and Restrictions

Use is established in adults. Due to the risk of growth retardation, long-term systemic use should be avoided in pediatric patients. Safety and efficacy in the pediatric ophthalmic context have not yet been established (regulatory criteria vary by region).

Patients with pre-existing conditions, including glaucoma (ocular use), diabetes mellitus, hypertension, and severe liver or kidney impairment, are eligible only under conditions that require frequent monitoring and great caution.

During pregnancy, use is restricted to cases where the potential benefit explicitly justifies the risk to the fetus. Breastfeeding mothers must make a decision to discontinue the drug or discontinue nursing.

What should I know about interactions with other medicines?

Hostacortin Interactions with other medicines and products

Hostacortin (prednisone) is a prodrug that is converted to the active substance, prednisolone, in the liver, and its metabolism is influenced by several other medicines. Interactions primarily relate to alterations in the activity of cytochrome P450 (CYP) enzymes, particularly CYP3A4, or changes in electrolytes.

Interacting Product Category Example Medicines/Substances Interaction Outcome (Risk)
CYP3A4 Inducers Rifampin, Phenytoin, Barbiturates, St John's Wort May decrease prednisolone plasma concentrations, leading to reduced efficacy.
CYP3A4 Inhibitors Ketoconazole, Macrolide antibiotics (e.g., Clarithromycin) May increase prednisolone plasma concentrations, potentially increasing the risk of adverse effects.
Potassium-Depleting Agents Diuretics, Amphotericin B Increased risk of severe hypokalemia (low potassium).
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Aspirin, Ibuprofen, Naproxen Increased risk of gastrointestinal ulcers and bleeding.
Warfarin Anticoagulants Effects of Warfarin may be altered; requires frequent monitoring of blood clotting indices.

Interaction Constraint: The concurrent use of St John's wort (Hypericum perforatum) must be avoided, as it is a potent enzyme inducer that can significantly reduce the concentration of the active glucocorticoid in the body, which may result in a loss of therapeutic effect.

Mechanism of Action

Hostacortin's active component, prednisolone, is a synthetic glucocorticoid that functions as an agonist for the Cytoplasmic Glucocorticoid Receptor (GR). This binding event initiates a functional change: the prednisolone-GR complex translocates into the cell nucleus to modulate gene expression. This genomic modulation operates via two parallel processes: Transactivation, increasing the synthesis of anti-inflammatory proteins like Lipocortin-1, and Transrepression, inhibiting pro-inflammatory transcription factors such as NF-κB.

The resultant Lipocortin-1 centrally interferes with early chemical cascades by inhibiting the enzyme Cytosolic Phospholipase A2 (cPLA2). Blocking cPLA2 prevents the synthesis of downstream mediators, specifically Prostaglandins and Leukotrienes. This suppression of mediator production decreases vascular permeability, resulting in reduced tissue fluid accumulation and widespread modulation of the systemic inflammatory response. The maximal suppression of the immune response is subject to a mechanism-dependent onset delay, and the activation of the GR triggers negative feedback on the Hypothalamic-Pituitary-Adrenal (HPA) axis.

Dosage and Administration Information

Administration Scope and Dosage

Hostacortin, containing prednisolone, is administered via two primary routes: Oral (for systemic use, including tablets and solutions) and Topical Ophthalmic (using a specialized suspension for localized eye application). Dosing for systemic use is highly variable and is individualized, with starting adult ranges typically from 5 mg to 60 mg per day. The governing principle for long-term use is to maintain the lowest effective dosage for the shortest duration necessary.


Frequency and Contextual Instructions

Systemic administration may follow a single daily dose schedule or use divided doses multiple times a day. For chronic systemic therapy, a specific regimen known as Alternate Day Therapy (ADT) is recognized. Oral dosage forms are taken with food or milk to help mitigate potential gastrointestinal irritation. If taking a single daily systemic dose, it is typically administered in the morning.

Procedural and Age-Specific Rules

Specialized formulations require specific handling; the ophthalmic suspension is shaken well immediately prior to each use to ensure proper concentration delivery. In pediatric patients, the dose is calculated based on body weight or body surface area, which differs from standard adult ranges. If a dose is missed, it is taken as soon as possible, but not doubled if it is near the time for the next scheduled intake. Finally, long-term or high-dose therapy requires gradual dose reduction (tapering) upon discontinuation.

Recent Clinical Evidence

Hostacortin: Recent Clinical Evidence

Evidence for Use in Ophthalmic (Eye) Inflammation

Research exploring the use of the Hostacortin ophthalmic suspension (containing prednisolone acetate) is grounded primarily in short-term Randomized Controlled Trials (RCTs) and systematic reviews. These studies examined the use of the medicine in specific settings, such as following eye surgery, focusing on outcomes linked to local inflammatory or irritative states. Researchers monitored objective outcomes like the presence of inflammatory cells and flare in the anterior chamber of the eye, and the status of corneal swelling. They also tracked changes in Intraocular Pressure (IOP).

Findings report patterns observed in the studies related to measured changes in inflammatory markers during the immediate post-surgical period. The evidence contributes to understanding the time course of measured inflammation following such procedures. However, the evidence quality varies across studies, and follow-up durations were limited to the immediate recovery period. Consequently, long-term outcomes are generally not well characterized, and results apply only to the specific patient populations studied.

Evidence for Use in Systemic Inflammatory Conditions

Hostacortin's active component, prednisolone, was evaluated in research contexts involving unstable symptoms across a wide range of systemic immune-mediated conditions. The evidence base includes a large body of RCTs and systematic reviews that explored the medicine’s use in conditions characterized by fluctuating or episodic manifestations. Studies examined outcomes related to physical discomfort, systemic functional imbalance, and relapse frequency in certain chronic conditions.

Research describes patterns related to measured symptom evolution in the observed populations, and studies focusing on episodes of heightened symptoms monitored metrics such as hospitalization rates. It is important to note that comparative evidence against newer non-corticosteroid therapies is lacking in some areas, and data for certain subgroups (such as adults with multiple specific co-existing conditions) remain insufficient in large-scale dedicated RCTs. Data for children, however, has been specifically explored in research related to conditions like idiopathic nephrotic syndrome.

Key Studies & References

  1. KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children

Frequently Asked Questions (FAQ)

Common questions about Hostacortin (FAQ)


Q: What is the longest period of time someone usually takes Hostacortin?

Official regulatory documents indicate that the risk of certain adverse effects, such as HPA axis suppression and decreased bone density, is linked to the duration of systemic treatment. For chronic therapy, a specific regimen known as Alternate Day Therapy (ADT) is officially recognized. The goal described for long-term use is typically to maintain the lowest effective dosage for the shortest necessary duration.


Q: Does taking Hostacortin affect my ability to drive or operate machinery?

Official drug documents list potential effects on the nervous system and psychiatric disturbances, which may include dizziness, euphoria, insomnia, and mood swings. These documented effects indicate the potential for changes in coordination or focus. The official documents do not provide specific general instruction or guidance regarding operating machinery.


Q: What happens if I stop taking Hostacortin suddenly?

Abrupt discontinuation of Hostacortin following prolonged use can lead to a condition called acute adrenal insufficiency. This occurs because long-term use of the active ingredient suppresses the body's natural production of cortisol. Official documents describe that gradual dose reduction, or tapering, is necessary upon discontinuation.


Q: Are there any specific foods or drinks that should be avoided while on Hostacortin?

Official interaction lists specifically restrict the concurrent use of the herbal supplement St John's wort due to its ability to reduce the drug's effectiveness. Other patient resources may note general caution regarding the intake of large amounts of caffeine, which is associated with side effects like insomnia. Apart from St John's wort, no specific food or drink restrictions are noted in the primary regulatory labels.


Q: What is the difference between a common side effect and a serious adverse event for Hostacortin?

Official documents classify adverse reactions, organizing them by both frequency (e.g., common) and severity (e.g., serious). For example, weight gain and increased appetite are noted as common reactions. In contrast, peptic ulceration with perforation is documented as a serious adverse reaction.


Q: Can Hostacortin be used in combination with an antibiotic?

Official drug interaction lists include certain macrolide antibiotics (e.g., clarithromycin) as agents that may increase the concentration of the active ingredient in the body. The ophthalmic form may also be used alongside an antimicrobial agent if an infection is present in the eye. The combination of Hostacortin with other drugs may be addressed in specific clinical scenarios.


Q: What does the term 'systemic exposure' mean for Hostacortin?

Systemic exposure refers to the active medicine reaching the bloodstream and affecting the entire body, as opposed to being applied locally or topically (e.g., when an eye drop formulation is used). The oral form of Hostacortin is considered a systemic treatment. The risks associated with the drug are often related to the duration and extent of systemic exposure.


Q: What happens to the body's natural hormones when taking Hostacortin?

The drug's active component suppresses the body's natural production of cortisol (a natural glucocorticoid) by inhibiting the Hypothalamic-Pituitary-Adrenal (HPA) axis. This suppression of natural hormone production can lead to secondary adrenocortical unresponsiveness with prolonged use. This effect is central to the drug’s mechanism and discontinuation requirements.


Q: How quickly should I expect to see an effect from Hostacortin?

For the localized ophthalmic use, official documents state that if signs and symptoms fail to improve after 2 days, re-evaluation is needed. For systemic use, the maximal suppression of the immune response is subject to a mechanism-dependent onset delay. The onset of full therapeutic effect is subject to individual variation.


Q: What is Hostacortin typically prescribed for?

Official indications for the active ingredient cover a broad range of conditions where anti-inflammatory and immunosuppressive effects are needed. This includes various allergic conditions, certain dermatologic diseases (such as severe erythema multiforme), gastrointestinal diseases (like acute episodes of ulcerative colitis), and ophthalmic inflammatory conditions.


Q: Is it normal to feel a change in energy levels after starting Hostacortin?

Official drug information lists potential side effects related to energy and mental state. These include reported feelings of extreme tiredness and weak muscles. The behavioral and mood disturbances section also notes the possibility of euphoria, which can be associated with energy changes.


Q: Can Hostacortin cause dependency?

Regulatory-sourced information indicates that long-term use can cause physical dependence due to the body's reliance on the drug for adrenal function. Instead, the physical dependence is related to the body's reliance on the drug for adrenal function.


Q: Can older adults safely use Hostacortin?

The official label does not specify that the effectiveness or safety differs in the elderly compared to younger adults. However, it notes that older adults may be at greater risk for certain effects, such as decreased bone density, which is stated to require monitoring. Individual circumstances will determine appropriateness of use.


Q: Are there special considerations for children taking Hostacortin?

Yes, special considerations are noted for pediatric patients in official documents. These primarily include the risk of growth retardation with long-term systemic use. Because of this, doses for children are calculated based on body weight or surface area rather than standard adult ranges.


Q: Does Hostacortin affect fertility?

Based on official research themes for the active ingredient, the use of the drug is not expected to make it harder to get pregnant. Research has noted its use in contexts where it was examined for potential effects on sperm motility.


Q: Is it true that Hostacortin can cause weight gain?

Yes, official regulatory documents list both increased appetite and weight gain as common adverse reactions associated with the medicine. This effect is often attributed to changes in metabolism and potential fluid retention.


Q: Can Hostacortin cause mood changes or sleep problems?

Yes, regulatory documents list effects on the nervous system and psychiatric function. Adverse reactions include euphoria, insomnia (difficulty sleeping), mood swings, and the potential for severe psychiatric disturbances.


Q: How does Hostacortin interact with common over-the-counter pain relievers?

Official documentation identifies an increased risk of gastrointestinal ulcers and bleeding when the medicine is used concurrently with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). This group includes common over-the-counter pain relievers such as ibuprofen or naproxen. Official documentation identifies a need for awareness regarding concurrent use.


Q: Is there a list of all known drug interactions for Hostacortin?

Official drug labels provide a list and category of known interactions, such as those involving CYP3A4 enzymes and potassium-depleting agents. The official interaction documents provide categories and examples, and they do not claim to be universally exhaustive of all possible interactions with every known substance.


Q: Is Hostacortin used for temporary conditions or long-term management?

Official indications show that the drug is used for both. It is indicated for treating acute episodes in chronic diseases (temporary critical periods) and for the long-term management of chronic or incapacitating conditions. Long-term use may require a specific alternate-day regimen.


Q: Does Hostacortin interact with herbal supplements or vitamins?

Yes, the concurrent use of the herbal supplement St John's wort is officially restricted because it can significantly decrease the concentration of the active drug. Other regulatory patient resources may also mention potential interactions, such as those related to licorice root or ginseng.


Q: Does Hostacortin affect blood pressure?

Yes, official adverse reaction lists include an elevation in blood pressure and effects on the cardiovascular system. Adverse reactions specifically noted include hypertension (high blood pressure) and the potential for congestive heart failure.


Q: Are there any known restrictions on food intake while taking this medicine?

The oral form of the medicine is specifically instructed to be taken with food or milk to reduce the risk of stomach irritation. Additionally, regulatory patient information suggests avoiding the herbal supplement St John's wort and limiting caffeine intake due to potential effects like insomnia.


Q: Is there any public research about the long-term effects of taking Hostacortin?

Official research sections indicate that long-term outcomes are generally not well characterized in the specific randomized controlled trials cited. Many of these studies had follow-up durations limited to the immediate recovery period, meaning long-term data for specific effects may not be included in the primary evidence base.


Q: What are the potential effects of Hostacortin on bone density?

Official warnings note that a decrease in bone density is associated with the long-term use of the active ingredient. This decrease can lead to osteoporosis and an increased risk of fractures. The risk is linked to the duration of use.


Q: Can I take Hostacortin if I have diabetes?

Patients with pre-existing conditions, including diabetes mellitus, are eligible only under conditions where frequent monitoring is described. This is because the drug can cause manifestations of latent diabetes mellitus and an increased requirement for insulin in those already on treatment.


Q: Can I take Hostacortin if I have a history of stomach ulcers?

Regulatory documents list a risk of peptic ulceration with potential for hemorrhage and perforation as possible side effects. The drug should be used with caution in patients who have pre-existing gastrointestinal disorders or a history of ulcers.


Q: Is it possible to be allergic to Hostacortin?

Yes, the medicine is contraindicated and must not be used by individuals with a known or suspected hypersensitivity to the active ingredient or any component of the formulation. This statement defines a known or suspected hypersensitivity as an absolute contraindication for use.


Q: Are there any specific laboratory tests required before starting Hostacortin?

Monitoring described in official documents includes checking intraocular pressure (IOP) during extended ophthalmic administration. Additionally, monitoring blood clotting indices is described when the drug is used with anticoagulants like warfarin.


Q: Does Hostacortin interact with blood thinners?

Yes, official documentation states that the drug may alter the effects of warfarin (a common anticoagulant or blood thinner). This potential interaction may increase or decrease the blood thinner's effect, where frequent monitoring of blood clotting indices is described.


Q: Can I use Hostacortin if I have an active infection?

Use of the medicine is prohibited in the presence of most viral, mycobacterial, and fungal infections, including systemic fungal infections. The drug is classified as an immunosuppressive agent, which means it can mask signs of infection or reduce the body's natural resistance to new infections.

How should Hostacortin be stored and disposed of?

How to Store and Dispose of Hostacortin

Official regulatory documents define specific conditions for storing and disposing of Hostacortin (prednisolone) to maintain product stability and safety.

Storage and Protection

The medication must be stored at or below 25°C (77°F). It is mandatory to protect the product from freezing and to keep it away from excessive heat and moisture. Always keep Hostacortin in its original container with the cap tightly closed when not in use. A crucial safety requirement is to store the medicine out of the sight and reach of children.

Disposal Requirements

Unused or expired medicine should not be flushed down the toilet. The preferred method for disposal is to utilize a drug take-back program or an authorized collection point. If a take-back program is unavailable, mix the medicine with an undesirable substance, seal it in a container, and dispose of it with household trash, following local pharmaceutical waste regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hostacortin found in:

A-Z Index: